No menu items!

Covaxin manufacturer says advance payment is common, but Brazil was exception

RIO DE JANEIRO, BRAZIL - Indian pharmaceutical company Bharat Biotech on Wednesday published a note with clarifications on its procedures for the sale of the Covaxin vaccine to the Brazilian government. Due to accusations of irregularities, the contract was suspended by Brazil's Ministry of Health yesterday, June 29.

According to the pharmaceutical company, the prepayment requirement is adopted in several countries before vaccines are shipped, but the contract with Brazil was different and no amount . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?

Check out our other content